PTH and Marchiafava-Bignami disease: Third, clinical practice should formalize integrated, longitudinal monitoring: combining PTH trends with calcium, phosphate, and bone-specific ALP, rather than relying on isolated measurements, to better reflect bone turnover and cardiovascular risk in CKD-MBD (100).